Mixed-effects models revealed a significant difference between the venlafaxine XR and placebo groups in improvement on the Maier subscale from baseline to @ weeks ( treatment effect , @ ; @ % CI , @-@ @ ; P = @ ) but not on the HAM-D @-item version ( treatment effect , @ ; @ % CI , -@ to @ ; P = @ ) .